Sernova Corp banner

Intrinsic Value

The intrinsic value of Sernova Corp (SVA) under the Base Case is 0.19 CAD per share. Compared with the current market price of 0.105 CAD, the stock appears Undervalued by 45% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

SVA Intrinsic Value
CA$0.19
Undervaluation 45%
Intrinsic Value
Price CA$0.105
Alert me when SVA is below its intrinsic value
Today CA$0.095 · 9.4% below the current price

SVA is cheaper than usual. It was this cheap or cheaper on just 3% of days in the past 5 years.

Alternatives to SVA

Fundamental Analysis

What Sernova Does

Biotechnology Health Care

Sernova Corp. is a clinical stage regenerative medicine company. The company is headquartered in London, Ontario. The firm is engaged in the development of its Cell Pouch and associated technologies, including therapeutic cells for the treatment of chronic diseases and local immune protection technologies. The company is focused on developing a treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted and prevascularized medical device, protected from immune system attack.

Headquarters
Canada CA
IPO date
Apr 15, 1999
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue SVA Research

Decided on Sernova? Get an email when SVA reaches the price you’d buy at. Free with an account.

Other Sernova listings

What is the Intrinsic Value of one SVA stock?

The intrinsic value for Sernova Corp (SVA) under the Base Case is 0.19 CAD.

Is SVA stock undervalued or overvalued?

Compared with the current market price of 0.105 CAD, the stock appears Undervalued by 45% .

How reliable are our estimates? See how past valuations played out
Back to Top